Blue Water Ventures International Inc(BWVI)
USD --+0.00%
Reward35Moderate
Risk38Moderate
📊75%Data
BWVI
+0.0 · +0.00%
USD · PINK
Blue Water Ventures International Inc | Healthcare
Capital Destroyer
Market Cap:110570
ℹ️
Reward Rating
35
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
38
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BWVI to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Blue Water Ventures International Inc?

, through its subsidiary, Psycheceutical Inc.

BWVI · Verdict

Limited reward · moderate risk

BWVI's standout is volatility; profitability and valuation weigh on the picture.

Based on 88% data coverage

BWVI · Verdict

What’s working & what to watch

Strengths 1

  • Volatility95/100

    Top decile vs peers

Watchouts 3

  • Profitability10/100

    0% return on equity

  • Valuation30/100

    Below average

  • Growth41/100

    Earnings +217.7% CAGR

Model-based scoring. For information only — not financial advice.

What is Blue Water Ventures International Inc?

, through its subsidiary, Psycheceutical Inc. , focuses on developing pharmaceutical products and technologies for mental health treatments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 110.57K.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (35)

The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap110.57K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.015
52 Week Low0.0001
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding276M
No. of EmployeesN/A
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
BetaN/A
CurrencyUSD